ID
14198
Beschrijving
Efficacy of Ciclesonide Inhaled Once Daily Versus Other Corticosteroids Used for Treatment of Mild Asthma in Children (4 to 11 y) (BY9010/CA-101); ODM derived from: https://clinicaltrials.gov/show/NCT00163293
Link
https://clinicaltrials.gov/show/NCT00163293
Trefwoorden
Versies (1)
- 04-04-16 04-04-16 -
Houder van rechten
CC BY-NC 3.0
Geüploaded op
4 april 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Asthma NCT00163293
Eligibility Asthma NCT00163293
- StudyEvent: Eligibility
Beschrijving
Exclusion criteria
Alias
- UMLS CUI-1
- C0680251
Beschrijving
life-threatening asthma
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0004096
- UMLS CUI [1,2]
- C2826244
Beschrijving
hospitalization for asthma
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0019993
- UMLS CUI [1,2]
- C0004096
Beschrijving
comorbidity limiting use of inhaled steroids
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0586793
- UMLS CUI [1,2]
- C0439801
- UMLS CUI [1,3]
- C0009488
Beschrijving
lung diseases
Datatype
boolean
Alias
- UMLS CUI [1]
- C0024115
Beschrijving
prematurely born children
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0008059
- UMLS CUI [1,2]
- C0151526
Beschrijving
smokers
Datatype
boolean
Alias
- UMLS CUI [1]
- C0543414
Beschrijving
pregnancy, lactation, contraception
Datatype
boolean
Alias
- UMLS CUI [1]
- C0032961
- UMLS CUI [2]
- C0006147
- UMLS CUI [3]
- C0700589
- UMLS CUI [4]
- C3831118
Similar models
Eligibility Asthma NCT00163293
- StudyEvent: Eligibility
C0205343 (UMLS CUI [1,2])
C2826244 (UMLS CUI [1,2])
C0004096 (UMLS CUI [1,2])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
C0151526 (UMLS CUI [1,2])
C0006147 (UMLS CUI [2])
C0700589 (UMLS CUI [3])
C3831118 (UMLS CUI [4])